Thursday, April 4, 2013

Surgeon Testifies that He Would Not Use ASR Hip Implant

Public Health Watchdog
April 3 2013

Overview: A surgeon who helped develop the DePuy ASR hip implant testified yesterday in Illinois state court that he would not use the recalled metal-on-metal hip device, Law 360 reports. Orthopedic surgeon Thomas P. Schmalzried testified before jurors in the second DePuy ASR trial weighing the lawsuit of Carol Strum, who alleges that the ASR hip implant is defective and caused injuries by releasing a toxic amount of metallic debris.
  • A surgeon who helped develop the DePuy ASR hip implant testified yesterday in the second DePuy ASR trial in Illinois
  • The surgeon told jurors that he would not use the ASR and stated that his own revision rate is unacceptable; he said that the benefits do not outweigh the risk
  • Carol Strum’s lawsuit is the second out of 10,000 lawsuits to go to trial
Product: DePuy ASR Hip Implant
Manufacturer: DePuy Orthopaedics/ Johnson & Johnson
Side Effects & Complications
  • High failure rate
  • Necrosis (tissue death)
  • Increased levels of cobalt and chromium ions
  • Pain at the implant, sometimes spreading to the groin and back
  • Osteolysis (bone loss)
  • Fluid collections/solid masses around the hip joint

Surgeon Testimony
Dr. Schmalzried testified that he himself revised 15 out of 66 ASR hip implants, and stated that this revision rate is unacceptable for hip implants. “I would not implant the ASR XL today,” he said to jurors. According to Law 360, he also agreed with the assertion that the benefits of the ASR do not outweigh its risks. Schmalzried is the first witness to testify for the defense in the trial weighing the lawsuit of Carol Strum, whose case is the second of over 10,000 to go to trial. She alleges that her ASR hip implant is defective and caused injuries such as pain and revision surgery by shedding dangerous amounts of metal debris into the bloodstream and local tissue.

DePuy ASR Lawsuits
The first DePuy ASR lawsuit to go to trial ended in an $8.3 million verdict for the Plaintiff, with jurors in Los Angeles ruling that the recalled metal-on-metal hip implant is defective and that Johnson & Johnson was negligent. J&J and its subsidiary DePuy recalled 93,000 ASR hip implants in 2010 due to a high revision rate. Since then, lawsuits have mounted over all-metal hip devices.

No comments:

Post a Comment